secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001609550-24-000004
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical Systems Q4 preliminary revenue ~$192.4M (+40% YoY); FY2024 guidance $775-785M
--------------------------------------------------------------------------------

- Q4 2023 revenue expected $192.3-192.5M, ~40% increase over Q4 2022.
- FY2023 revenue expected $624.6-624.8M, ~53% increase over FY2022.
- Added 78 new U.S. centers in Q4, total 1,180; 13 new sales territories, total 287.
- Initial FY2024 revenue guidance $775-785M, 24-26% growth over FY2023.
- Company expects to report a profitable Q4 when full results are released Feb 6, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955024000004/0001609550-24-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955024000004/insp-20240108.htm
  HTML page:      https://secwatch.observer/filing/0001609550-24-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer